Cardiovascular Risk Factors May Moderate Pharmacological Treatment Effects in Major Depressive Disorder
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: An increased association between depression and cardiovascular disease, as well as cardiovascular risk factors, led to the "vascular depression" hypothesis. This subtype of depression is postulated to have a different clinical presentation and to be more treatment-resistant. In this study, we measured the impact of cardiovascular risk factors on the outcome of antidepressant treatment in major depressive disorder (MDD). METHOD: We enrolled 348 MDD subjects, ages 19 to 65 years, in an 8-week treatment study with 20 mg fluoxetine per day. We recorded for each subject 6 cardiovascular risk factors: age (male > or =45, female > or =55), smoking, family history, hypertension, diabetes, hypercholesterolemia; and we defined a cardiovascular risk score (range, 0-6) by the number of risk factors present. Treatment outcome was measured as response (> or =50% improvement on the 17-item Hamilton Rating Scale for Depression [Ham-D-17]) and remission (final Ham-D-17< or =7). RESULTS: In logistic regression analyses, the cardiovascular risk score was significantly associated with treatment nonresponse and lack of remission when adjusting for age of onset of MDD and baseline severity of depression. The cardiovascular risk score remained significantly associated with treatment nonresponse when we additionally controlled for overall medical burden (measured with the Cumulative Illness Rating Scale). Among individual cardiovascular risk factors, elevated total cholesterol was a significant predictor of treatment nonresponse and lack of remission. CONCLUSION: Cardiovascular risk factors may have negative effects on the course of treatment in MDD. These results support the concept of "vascular depression" in younger subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“Moreover, high rates of depression have been reported in association with the total burden of vascular risk factors (12) and in relation to individual vascular risk factors such as hypertension (13,14), smoking (15,16), and diabetes (17, 18 ).”
BackgroundMiller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 4×
“Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.”
MethodInfluential'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 3×
“Recognition of the relationship between vascular disease and major depressive disorder has led investigators to describe “vascular depression,” a subtype of major depressive disorder (MDD) characterized by the presence of cerebrovascular disease (1,2).”
BackgroundMRI-defined vascular depression
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.497 · Cited by 770 · cited 2×
“Recognition of the relationship between vascular disease and major depressive disorder has led investigators to describe “vascular depression,” a subtype of major depressive disorder (MDD) characterized by the presence of cerebrovascular disease (1,2).”
BackgroundZiegelstein, R. C., Fauerbach, J. A., Stevens, S. S., Romanelli, J., Richter, D. P., & Bush, D. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1818 · Cited by 710
Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression
Alexopoulos, G. S., Kiosses, D. N., Murphy, C., & Heo, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300557 · Cited by 117
Sonawalla, S. B., Papakostas, G. I., Petersen, T. J., Yeung, A. S., Smith, M. M., Sickinger, A. H., Gordon, J., Israel, J. A., Tedlow, J. R., Lamon-Fava, S., et al. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.4.310 · Cited by 62
Self-citation
Cited by
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Isingrini, E., Camus, V., Le Guisquet, A.-M., Pingaud, M., Devers, S., & Belzung, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010404 · Cited by 277
“Moreover, cardiovascular risk factors like aging, smoking, hypertension, diabetes, hypercholesterolemia and advanced heart disease predict a poor response to fluoxetine/ citalopram treatment and lack of remission [8,9].”
BackgroundVascular depression consensus report – a critical update
Aizenstein, H. J., Baskys, A., Boldrini, M., Butters, M. A., Diniz, B. S., Jaiswal, M. K., Jellinger, K. A., Kruglov, L. S., Meshandin, I. A., Mijajlovic, M. D., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0720-5 · Cited by 258
Honig, A., Kuyper, A. M. G., Schene, A. H., van Melle, J. P., de Jonge, P., Tulner, D. M., Schins, A., Crijns, H. J. G. M., Kuijpers, P. M. J. C., Vossen, H., et al. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31814b260d · Cited by 167
Zou, Y.-F., Ye, D.-Q., Feng, X.-L., Su, H., Pan, F.-M., & Liao, F.-F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.005 · Cited by 104
Metadata
- Authors
- Iosifescu, D. V., Clementi-Craven, N., Fraguas, R., Papakostas, G. I., Petersen, T., Alpert, J. E., Nierenberg, A. A., & Fava, M.
- Venue
- Psychosomatic Medicine
- Published
- 2005-09
- Volume
- 67
- Issue
- 5
- Pages
- 703-706
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2046061745
- Cited by
- 72
- References
- 7
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Risk Factors May Moderate Pharmacological Treatment Effects in Major Depressive Disorder. https://app.cochat.ai/papers/10.1097/01.psy.0000170338.75346.d0
- The paper
- Iosifescu, D. V., Clementi-Craven, N., Fraguas, R., Papakostas, G. I., Petersen, T., Alpert, J. E., Nierenberg, A. A., & Fava, M. (2005). Cardiovascular Risk Factors May Moderate Pharmacological Treatment Effects in Major Depressive Disorder. Psychosomatic Medicine. https://doi.org/10.1097/01.psy.0000170338.75346.d0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.